SEC Form 4/A · accession 0001140361-16-059043
OncoMed Pharmaceuticals Inc · OMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Paul J Hastings
Officer — Chief Executive Officer · Director
Period of report
Dec 28, 2015
Accepted (ET)
Mar 25, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $22.10 | Dec 28, 2015 | A | 170,000 | A | — | Dec 27, 2025 | Common Stock | 170,000 | 170,000 | D |
Explanation of responses
- F1This amendment is filed to correct the grant date and exercise price of the option reported as acquired herein. This option was originally reported as acquired on December 27, 2015 at an exercise price of $21.43 per share.
- F2The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.